Oligonucleotide Therapeutic Unit, Pfizer, Cambridge, MA, USA.
Nucleic Acid Ther. 2012 Oct;22(5):344-59. doi: 10.1089/nat.2012.0366. Epub 2012 Aug 1.
A series of insertion patterns for chemically modified nucleotides [2'-O-methyl (2'-OMe), 2'-fluoro (2'-F), methoxyethyl (MOE), locked nucleic acid (LNA), and G-Clamp] within antisense gapmers is studied in vitro and in vivo in the context of the glucocorticoid receptor. Correlation between lipid transfection and unassisted (gymnotic--using no transfection agent) in vitro assays is seen to be dependent on the chemical modification, with the in vivo results corresponding to the unassisted assay in vitro. While in vitro mRNA knockdown assays are typically reasonable predictors of in vivo results, G-Clamp modified antisense oligonucleotides have poor in vivo mRNA knockdown as compared to transfected cell based assays. For LNA gapmers, knockdown is seen to be highly sensitive to the length of the antisense and number of LNA insertions, with longer 5LNA-10DNA-5LNA compounds giving less activity than 3LNA-10DNA-3LNA derivatives. Additionally, the degree of hepatoxicity for antisense gapmers with identical sequences was seen to vary widely with only subtle changes in the chemical modification pattern. While the optimization of knockdown and hepatic effects remains a sequence specific exercise, general trends emerge around preferred physical properties and modification patterns.
在糖皮质激素受体的背景下,研究了一系列化学修饰核苷酸(2'-O-甲基(2'-OMe)、2'-氟(2'-F)、甲氧基乙基(MOE)、锁核酸(LNA)和 G-夹)在反义寡核苷酸中的插入模式。在体外,未辅助(使用非转染剂的电穿孔)的实验与脂质转染之间存在相关性,结果发现这种相关性取决于化学修饰,而体内结果与体外未辅助实验相对应。虽然体外 mRNA 敲低实验通常可以合理地预测体内结果,但与基于转染细胞的测定相比,G-夹修饰的反义寡核苷酸在体内的 mRNA 敲低效果较差。对于 LNA 寡核苷酸,敲低对反义的长度和 LNA 插入的数量非常敏感,5LNA-10DNA-5LNA 化合物的活性低于 3LNA-10DNA-3LNA 衍生物。此外,具有相同序列的反义寡核苷酸的肝毒性程度差异很大,而化学修饰模式的变化很小。虽然敲低和肝效应的优化仍然是一个序列特异性的问题,但在物理性质和修饰模式方面出现了一些共同的趋势。